Differential effectiveness of placebo treatments: A systematic review of migraine prophylaxis

JAMA Internal Medicine

Volumn 173, Issue 21, 2013, Pages 1941-1951

  Meissner, Karin ^a,b   Fässler, Margrit ^a,c   Rücker, Gerta ^d   Kleijnen, Jos ^e,f   Hróbjartsson, Asbjorn ^g   Schneider, Antonius ^a   Antes, Gerd ^d   Linde, Klaus ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d UNIVERSITY OF FREIBURG   (Germany)

^e KLEIJNEN SYSTEMATIC REVIEWS LTD   (United Kingdom)

^f MAASTRICHT UNIVERSITY   (Netherlands)

^g Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

ACUPUNCTURE; ARTICLE; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; EFFECT SIZE; EXPERIMENTAL THERAPY; HEADACHE; HUMAN; META ANALYSIS; MIGRAINE; OUTCOME ASSESSMENT; PHYSICIAN; PLACEBO EFFECT; PREDICTION; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SHAM PROCEDURE; SYSTEMATIC REVIEW; TREATMENT RESPONSE;

ACUPUNCTURE THERAPY; DRUG ADMINISTRATION SCHEDULE; HUMANS; MIGRAINE DISORDERS; NEUROSURGICAL PROCEDURES; PLACEBO EFFECT; PLACEBOS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84890017792     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2013.10391     Document Type: Article

References (104)

1. Kaptchuk TJ, Stason WB, Davis RB, et al. Sham device v inert pill: randomised controlled trial of two placebo treatments. BMJ. 2006;332(7538):391- 397.
2. De Craen AJ, Tijssen JG, De Gans J, Kleijnen J. Placebo effect in the acute treatment of migraine: subcutaneous placebos are better than oral placebos. J Neurol. 2000;247(3):183-188.
3. Kaptchuk TJ, Goldman P, Stone DA, Stason WB. Do medical devices have enhanced placebo effects? J Clin Epidemiol. 2000;53(8):786-792.
4. Di Blasi Z, Harkness E, Ernst E, Georgiou A, Kleijnen J. Influence of context effects on health outcomes: a systematic review. Lancet. 2001;357(9258):757-762.
5. Bergmann JF, Chassany O, Gandiol J, et al. A randomised clinical trial of the effect of informed consent on the analgesic activity of placebo and naproxen in cancer pain. Clin Trials Metaanal. 1994;29(1):41-47.
6. Walach H. The efficacy paradox in randomized controlled trials of CAM and elsewhere: beware of the placebo trap. J Altern Complement Med. 2001;7(3):213-218.
7. Watson RJ, Richardson PH. Identifying randomized controlled trials of cognitive therapy for depression: comparing the efficiency of EMBASE, MEDLINE and PsycINFO bibliographic databases. Br J Med Psychol. 1999;72(pt 4):535-542.
8. Higgins J P T, Altman DG, Sterne J A C. Assessing risk of bias in included studies. In: Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [Updated September 2009]. Cochrane Collaboration; 2011. http://handbook.cochrane.org/. Accessed November 10, 2009.
9. Li T, Puhan MA, Vedula SS, Singh S, Dickersin K; Ad Hoc Network Meta-analysis Methods Meeting Working Group. Network meta-analysis-highly attractive but more methodological research is needed. BMC Med. 2011;9(1):79. doi:10.1186/1741-7015-9-79.
10. Mills EJ, Bansback N, Ghement I, et al. Multiple treatment comparison meta-analyses: a step forward into complexity. Clin Epidemiol. 2011;3:193-202.
11. Puhan MA, Bachmann LM, Kleijnen J, Ter Riet G, Kessels AG. Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis. BMC Med. 2009;7:2. doi:10.1186/1741-7015-7-2.
12. Salanti G, Higgins JP, Ades AE, Ioannidis JP. Evaluation of networks of randomized trials. Stat Methods Med Res. 2008;17(3):279-301.
13. Wolff RF, Bala MM, Westwood M, Kessels AG, Kleijnen J. 5% Lidocaine-medicated plaster vs other relevant interventions and placebo for post-herpetic neuralgia (PHN): a systematic review. Acta Neurol Scand. 2011;123(5):295-309.
14. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-560.
15. Schwarzer G. meta: An R package for meta-analysis. R News. 2007;7(3):40-45.
16. Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36(3):1-48.
17. Adly C, Straumanis J, Chesson A. Fluoxetine prophylaxis of migraine. Headache. 1992;32(2):101-104.
18. Alecrim-Andrade J, Maciel-Júnior JA, Carné X, Correia-Filho HR, Machado HC, Vasconcelos G M S. Efficacy of acupuncture in migraine attack prophylaxis: a randomized sham-controlled trial. Cephalalgia. 2005;25(10):942.
19. Alecrim-Andrade J, Maciel-Júnior JA, Carnè X, Severino Vasconcelos GM, Correa-Filho HR. Acupuncture in migraine prevention: a randomized sham controlled study with 6-months posttreatment follow-up. Clin J Pain. 2008;24(2):98-105.
20. Alecrim-Andrade J, Maciel-Júnior JA, Cladellas XC, Correa-Filho HR, Machado HC. Acupuncture in migraine prophylaxis: a randomized sham-controlled trial. Cephalalgia. 2006;26(5):520-529.
21. Anand KS, Prasad A, Singh MM, Sharma S, Bala K. Botulinum toxin type A in prophylactic treatment of migraine. Am J Ther. 2006;13(3):183-187.
22. Andersson PG, Dahl S, Hansen JH, et al. Prophylactic treatment of classical and non-classical migraine with metoprolol: a comparison with placebo. Cephalalgia. 1983;3(4):207-212.
23. Baust W, Stürtzbecher KH. Management of migraine using acupuncture in a double-blind study [in German]. Med Welt. 1978;29(16):669-673.
24. Blanchard EB, Appelbaum KA, Radnitz CL, et al. A controlled evaluation of thermal biofeedback and thermal biofeedback combined with cognitive therapy in the treatment of vascular headache. J Consult Clin Psychol. 1990;58(2):216-224.
25. Blanchard EB, Peters ML, Hermann C, et al. Direction of temperature control in the thermal biofeedback treatment of vascular headache. Appl Psychophysiol Biofeedback. 1997;22(4):227-245.
26. Bousser MG, Chick J, Fuseau E, Soisson T, Thevenet R. Combined low-dose acetylsalicylic acid and dihydroergotamine in migraine prophylaxis: a double-blind, placebo-controlled crossover study. Cephalalgia. 1988;8(3):187-192.
27. Boutouyrie P, Corvisier R, Ong KT, et al. Acute and chronic effects of acupuncture on radial artery: a randomized double blind study in migraine. Artery Res. 2010;4(1):7-14.
28. Brandes JL, Saper JR, Diamond M, et al; MIGR-002 Study Group. Topiramate for migraine prevention: a randomized controlled trial. JAMA. 2004;291(8):965-973.
29. Brown JM. Imagery coping strategies in the treatment of migraine. Pain. 1984;18(2):157-167.
30. Cady R, Schreiber C. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues. Headache. 2008;48(6):900-913.
31. Cady RK, Mathew N, Diener H-C, Hu P, Haas M, Novak GP; Study Group. Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trial. Headache. 2009;49(2):216-226.
32. Carasso RL, Yehuda S. The prevention and treatment of migraine with an analgesic combination. Br J Clin Pract. 1984;38(1):25-27.
33. Carrieri P, Orefice G, Sorge F. Indobufen, a new antiaggregant drug, in the treatment of migraine: a double-blind study compared with placebo. Cephalalgia. 1985;5(suppl 3):546-547.
34. Ceccherelli F, Ambrosio F, Avila M, Duse G, Munari A, Giron GP. Acupuncture vs placebo in the common migraine: a double blind study. Cephalalgia. 1987;7(suppl 6):499-500.
35. Chankrachang S, Arayawichanont A, Poungvarin N, et al. Prophylactic botulinum type A toxin complex (Dysport®) for migraine without aura. Headache. 2011;51(1):52-63.
36. Cruz A, Bühling M, Seibel K. Double blind study of migraine therapy with etilefrine pivalate [in German]. Arzneimittelforschung. 1985;35(7):1086-1089.
37. De Tommaso M, Marinazzo D, Nitti L, et al. Effects of levetiracetam vs topiramate and placebo on visually evoked phase synchronization changes of alpha rhythm in migraine. Clin Neurophysiol. 2007;118(10):2297-2304.
38. Di Trapani G, Mei D, Marra C, Mazza S, Capuano A. Gabapentin in the prophylaxis of migraine: a double-blind randomized placebo-controlled study. Clin Ter. 2000;151(3):145-148.
39. Diener HC, Föh M, Iaccarino C, et al. Cyclandelate in the prophylaxis of migraine: a randomized, parallel, double-blind study in comparison with placebo and propranolol: the study group. Cephalalgia. 1996;16(6):441-447.
40. Diener HC, Kronfeld K, Boewing G, et al; GERAC Migraine Study Group. Efficacy of acupuncture for the prophylaxis of migraine: a multicentre randomised controlled clinical trial. Lancet Neurol. 2006;5(4):310-316.
41. Diener HC, Pfaffenrath V, Schnitker J, Friede M, Henneicke-Von Zepelin HH. Efficacy and safety of 6.25 mg t.i.d. Feverfew CO2-extract (MIG-99) in migraine prevention: a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia. 2005;25(11):1031-1041.
42. Diener H-C, Tfelt-Hansen P, Dahlöf C, et al; MIGR-003 Study Group. Topiramate in migraine prophylaxis: results from a placebo-controlled trial with propranolol as an active control. J Neurol. 2004;251(8):943-950.
43. Dowson A, Mullen MJ, Peatfield R, et al. Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache [published correction appears in Circulation. 2009;120(9):e71-e72]. Circulation. 2008;117(11):1397-1404.
44. Dowson DI, Lewith GT, Machin D. The effects of acupuncture versus placebo in the treatment of headache. Pain. 1985;21(1):35-42.
45. D'Souza PJ, Lumley MA, Kraft CA, Dooley JA. Relaxation training and written emotional disclosure for tension or migraine headaches: a randomized, controlled trial. Ann Behav Med. 2008;36(1):21-32.
46. Edwards KR, Potter DL, Wu S-C, Kamin M, Hulihan J. Topiramate in the preventive treatment of episodic migraine: a combined analysis from pilot, double-blind, placebo-controlled trials. CNS Spectr. 2003;8(6):428-432.
47. Elkind AH, O'Carroll P, Blumenfeld A, DeGryse R, Dimitrova R; BoNTA-024-026-036 Study Group. A series of three sequential, randomized, controlled studies of repeated treatments with botulinum toxin type A for migraine prophylaxis. J Pain. 2006;7(10):688-696.
48. Evers S, Vollmer-Haase J, Schwaag S, Rahmann A, Husstedt IW, Frese A. Botulinum toxin A in the prophylactic treatment of migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia. 2004;24(10):838-843.
49. Facco E, Liguori A, Petti F, et al. Traditional acupuncture in migraine: a controlled, randomized study. Headache. 2008;48(3):398-407.
50. Freitag FG, Collins SD, Carlson HA, et al; Depakote ER Migraine Study Group. A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis. Neurology. 2002;58(11):1652-1659.
51. Gauthier J, Bois R, Allaire D, Drolet M. Evaluation of skin temperature biofeedback training at two different sites for migraine. J Behav Med. 1981;4(4):407-419.
52. Gauthier J, Doyon J, Lacroix R, Drolet M. Blood volume pulse biofeedback in the treatment of migraine headache: a controlled evaluation. Biofeedback Self Regul. 1983;8(3):427-442.
53. Goadsby PJ, Ferrari MD, Csanyi A, Olesen J, Mills JG; Tonabersat TON-01-05 Study Group. Randomized, double-blind, placebo-controlled, proof-of-concept study of the cortical spreading depression inhibiting agent tonabersat in migraine prophylaxis. Cephalalgia. 2009;29(7):742-750.
54. Grossman W, Schmidramsl H. An extract of Petasites hybridus is effective in the prophylaxis of migraine. Altern Med Rev. 2001;6(3):303-310.
55. Guyuron B, Kriegler JS, Davis J, Amini SB. Comprehensive surgical treatment of migraine headaches. Plast Reconstr Surg. 2005;115(1):1-9.
56. Guyuron B, Reed D, Kriegler JS, Davis J, Pashmini N, Amini S. A placebo-controlled surgical trial of the treatment of migraine headaches. Plast Reconstr Surg. 2009;124(2):461-468.
57. Hauge AW, Asghar MS, Schytz HW, Christensen K, Olesen J. Effects of tonabersat on migraine with aura: a randomised, double-blind, placebo-controlled crossover study. Lancet Neurol. 2009;8(8):718-723.
58. Henry P. Headaches and acupuncture. In: Pfaffenrath V, Lundberg PO, Sjaastad O, eds. Updating in Headache. Berlin, Germany: Springer-Verlag; 1985:208-216.
59. Høivik HO, Laurijssens BE, Harnisch LO, et al. Lack of efficacy of the selective iNOS inhibitor GW274150 in prophylaxis of migraine headache. Cephalalgia. 2010;30(12):1458-1467.
60. Holroyd KA, Cottrell CK, O'Donnell FJ, et al. Effect of preventive (ß blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial. BMJ. 2010;341:c4871. doi:10.1136/bmj.c4871.
61. Kewman D, Roberts AH. Skin temperature biofeedback and migraine headaches: a double-blind study. Biofeedback Self Regul. 1980;5(3):327-345.
62. Kubiena G, Nissel H, Porenta G, Veitl M, Wessely P. Acupuncture in migraine: follow-up study [in German]. Deutsche Zeitschrift fur Akupunktur. 1992;35(6):140-148.
63. Leandri M, Rigardo S, Schizzi R, Parodi CI. Migraine treatment with nicardipine. Cephalalgia. 1990;10(3):111-116.
64. Linde K, Streng A, Jürgens S, et al. Acupuncture for patients with migraine: a randomized controlled trial. JAMA. 2005;293(17):2118-2125.
65. Lipton RB, Göbel H, Einhäupl KM, Wilks K, Mauskop A. Petasites hybridus root (butterbur) is an effective preventive treatment for migraine. Neurology. 2004;63(12):2240-2244.
66. Louis P. A double-blind placebo-controlled prophylactic study of flunarizine (Sibelium) in migraine. Headache. 1981;21(6):235-239.
67. Maizels M, Blumenfeld A, Burchette R. A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial. Headache. 2004;44(9):885-890.
68. Mei D, Capuano A, Vollono C, et al. Topiramate in migraine prophylaxis: a randomised double-blind versus placebo study. Neurol Sci. 2004;25(5):245-250.
69. Mendenopoulos G, Manafi T, Logothetis I, Bostantjopoulou S. Flunarizine in the prevention of classical migraine: a placebo-controlled evaluation. Cephalalgia. 1985;5(1):31-37.
70. Mikkelsen B, Pedersen KK, Christiansen LV. Prophylactic treatment of migraine with tolfenamic acid, propranolol and placebo. Acta Neurol Scand. 1986;73(4):423-427.
71. Mullinix JM, Norton BJ, Hack S, Fishman MA. Skin temperature biofeedback and migraine. Headache. 1978;17(6):242-244.
72. Orholm M, Honoré PF, Zeeberg I. A randomized general practice group-comparative study of femoxetine and placebo in the prophylaxis of migraine. Acta Neurol Scand. 1986;74(3):235-239.
73. Osterman PO. A comparison between placebo, pizotifen and 1-isopropyl-3-hydroxy-5-semicarbazono-6-oxo-2.3.5.6-tetrahydroindol (Divascan) in migraine prophylaxis. Acta Neurol Scand. 1977;56(1):17-28.
74. Peikert A, Wilimzig C, Köhne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia. 1996;16(4):257-263.
75. Petri S, Tölle T, Straube A, Pfaffenrath V, Stefenelli U, Ceballos-Baumann A; Dysport Migraine Study Group. Botulinum toxin as preventive treatment for migraine: a randomized double-blind study. Eur Neurol. 2009;62(4):204-211.
76. Pfaffenrath V, Diener HC, Fischer M, Friede M, Henneicke-von Zepelin HH; Investigators. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis: a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia. 2002;22(7):523-532.
77. Pfaffenrath V, Wessely P, Meyer C, et al. Magnesium in the prophylaxis of migraine: a double-blind placebo-controlled study. Cephalalgia. 1996;16(6):436-440.
78. Saper JR, Mathew NT, Loder EW, DeGryse R, Van Denburgh AM; BoNTA-009 Study Group. A double-blind, randomized, placebo-controlled comparison of botulinum toxin type A injection sites and doses in the prevention of episodic migraine. Pain Med. 2007;8(6):478-485.
79. Silberstein S, Mathew N, Saper J, Jenkins S; BOTOX Migraine Clinical Research Group. Botulinum toxin type A as a migraine preventive treatment. Headache. 2000;40(6):445-450.
80. Silberstein SD, Hulihan J, Karim MR, et al. Efficacy and tolerability of topiramate 20 mg/d in the prevention of migraine with/without aura in adults: a randomized, placebo-controlled, double-blind, 12-week pilot study. Clin Ther. 2006;28(7):1002-1011.
81. Silberstein SD, Neto W, Schmitt J, Jacobs D; MIGR-001 Study Group. Topiramate in migraine prevention: results of a large controlled trial. Arch Neurol. 2004;61(4):490-495.
82. Siniatchkin M, Andrasik F, Kropp P, et al. Central mechanisms of controlled-release metoprolol in migraine: a double-blind, placebo-controlled study. Cephalalgia. 2007;27(9):1024-1032.
83. Sjaastad O, Stensrud P. Appraisal of BC-105 in migraine prophylaxis. Acta Neurol Scand. 1969;45(5):594-600.
84. Somerville BW, Herrmann WM. Migraine prophylaxis with Lisuride hydrogen maleate-a double blind study of Lisuride versus placebo. Headache. 1978;18(2):75-79.
85. Spigt MG, Kuijper EC, Schayck CP, et al. Increasing the daily water intake for the prophylactic treatment of headache: a pilot trial. Eur J Neurol. 2005;12(9):715-718.
86. Storey JR, Calder CS, Hart DE, Potter DL. Topiramate in migraine prevention: a double-blind, placebo-controlled study. Headache. 2001;41(10):968-975.
87. Straumsheim P, Borchgrevink C, Mowinckel P, Kierulf H, Hafslund O. Homeopathic treatment of migraine: a double blind, placebo controlled trial of 68 patients. Br Homeopath J. 2000;89(1):4-7.
88. Teepker M, Hötzel J, Timmesfeld N, et al. Low-frequency rTMS of the vertex in the prophylactic treatment of migraine. Cephalalgia. 2010;30(2):137-144.
89. Tuchin PJ, Pollard H, Bonello R. A randomized controlled trial of chiropractic spinal manipulative therapy for migraine. J Manipulative Physiol Ther. 2000;23(2):91-95.
90. Vahedi K, Taupin P, Djomby R, et al; DIAMIG Investigators. Efficacy and tolerability of acetazolamide in migraine prophylaxis: a randomised placebo-controlled trial. J Neurol. 2002;249(2):206-211.
91. Vo AH, Satori R, Jabbari B, et al. Botulinum toxin type-a in the prevention of migraine: a double-blind controlled trial. Aviat Space Environ Med. 2007;78(5) (suppl):B113-B118.
92. Weber RB, Reinmuth OM. The treatment of migraine with propranolol. Neurology. 1972;22(4):366-369.
93. Weinschütz T, Niederberger U, Johnsen S, Schreiber C, Kropp P. The neuroregulative effects of acupuncture in patients with headache [in German]. Deutsche Zeitschrift fur Akupunktur. 1994;37(5):106-117.
94. Hróbjartsson A, Gøtzsche PC. Placebo interventions for all clinical conditions. Cochrane Database Syst Rev. 2010;(1): CD003974.
95. Linde K, Niemann K, Meissner K. Are sham acupuncture interventions more effective than (other) placebos? a re-analysis of data from the Cochrane review on placebo effects. Forsch Komplementmed. 2010;17(5):259-264.
96. Meissner K, Bingel U, Colloca L, Wager TD, Watson A, Flaten MA. The placebo effect: advances from different methodological approaches. J Neurosci. 2011;31(45):16117-16124.
97. Benedetti F, Amanzio M. The placebo response: how words and rituals change the patient's brain. Patient Educ Couns. 2011;84(3):413-419.
98. Kaptchuk TJ. Placebo studies and ritual theory: a comparative analysis of Navajo, acupuncture and biomedical healing. Philos Trans R Soc Lond B Biol Sci. 2011;366(1572):1849-1858.
99. Kerr CE, Shaw JR, Conboy LA, Kelley JM, Jacobson E, Kaptchuk TJ. Placebo acupuncture as a form of ritual touch healing: a neurophenomenological model. Conscious Cogn. 2011;20(3):784-791.
100. Birch S. A review and analysis of placebo treatments, placebo effects, and placebo controls in trials of medical procedures when sham is not inert. J Altern Complement Med. 2006;12(3):303-310.
101. Lund I, Lundeberg T. Are minimal, superficial or sham acupuncture procedures acceptable as inert placebo controls? Acupunct Med. 2006;24(1):13-15.
102. Macedo A, Farré M, Baños JE. A meta-analysis of the placebo response in acute migraine and how this response may be influenced by some of the characteristics of clinical trials. Eur J Clin Pharmacol. 2006;62(3):161-172.
103. Brunoni AR, Lopes M, Kaptchuk TJ, Fregni F. Placebo response of non-pharmacological and pharmacological trials in major depression: a systematic review and meta-analysis. PLoS One. 2009;4(3):e4824.
104. Hróbjartsson A, Kaptchuk TJ, Miller FG. Placebo effect studies are susceptible to response bias and to other types of biases. J Clin Epidemiol. 2011;64(11):1223-1229.